logo

RGLS(Delisted)

Regulus TherapeuticsยทNASDAQ
--
--(--)

RGLS Profile

Regulus Therapeutics Inc.

A biopharmaceutical company that developing therapeutics to target microRNAs

--
09/06/2007
10/04/2012
NASDAQ Stock Exchange
34
12-31
Common stock
4224 Campus Point Court, Suite 210, San Diego , CA 92121
--
Regulus Therapeutics Inc., was incorporated in Delaware on September 6, 2007. The company is a clinical-stage biopharmaceutical company dedicated to the discovery and development of first-in-class drugs targeting microRNAs to treat diseases with significant medical needs.